Preoperative and Postoperative Comparison of Two Nerve Blocks in Intertrochanteric Fracture Surgery
NCT ID: NCT07075432
Last Updated: 2025-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
64 participants
OBSERVATIONAL
2025-05-19
2025-11-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this single-center, prospective, observational study is to compare the effects of pericapsular nerve block and anterior quadratus lumborum block on spinal anesthesia positioning pain and postoperative analgesia in patients undergoing surgery for intertrochanteric femur fractures. Our study distinguishes itself by providing scientific guidance, as there are no studies in the literature comparing the effects of these two blocks on spinal anesthesia positioning pain, spinal anesthesia success, and postoperative analgesia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Femoral Nerve Block vs Peri-capsular Nerve Group Block for Hip Fracture Analgesia
NCT05444803
Peroperative Effect of Regional Anesthesia in Hip Surgery
NCT05960253
Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.
NCT06183541
Evaluation of Pericapsular Nerve Group Block on Positioning Pain for Spinal Anesthesia in Hip Fracture Patients
NCT04871061
Comparison of the Effects of Pericapsular Nerve Group (PENG), Suprainguinal Fascia Iliaca Compartment (S-FICB) and 3-1 Blocks on Comfort in Positioning for Unilateral Spinal Anesthesia and Postoperative Pain in Hip Fracture Surgery
NCT05912101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be transferred to the operating table for spinal anesthesia 30 minutes after the block. Hemodynamic data (SpO2, blood pressure, and pulse rate) will be recorded as is the routine preoperative and intraoperative process. During this process, the patient's resting pain before the block, dynamic pain before the block (leg pain at 15 degrees of elevation), resting pain at 30 minutes after the block, dynamic pain at 30 minutes after the block (leg pain at 15 degrees of elevation), and pain in the given position during spinal anesthesia will be recorded using a numerical rating scale (NRS). (The Numerical Rating Scale (NRS) is a pain score used to rate pain. During this score measurement, patients are asked to verbally state a number that corresponds to their pain, place a check mark on the number indicating their pain, or point to the number. The scale ranges from 0 to 10. 0 indicates no pain, while 10 represents the worst possible pain. Additionally, the anesthesiologist's block application times and whether spinal anesthesia was successful on the first attempt will be recorded. Patients in each group will be included in the group based on their demographic characteristics. After the procedure, patients will be admitted to the postoperative care unit as usual. Patients with an Aldrete score \>9 will be transferred to the ward (The Aldrete Scoring System is a scoring system that reflects physiological recovery after anesthesia. This system examines five parameters: muscle activity, respiration, circulation, consciousness, and oxygen saturation. Each parameter is assigned a score of 0, 1, or 2, with a maximum total score of 10).
Patients' rest pain will be assessed and recorded using a numerical rating scale (NRS) at 1 hour, 4 hours, 8 hours, 12 hours, and 24 hours postoperatively. All patients will be routinely administered 50 mg dexketoprofen intravenously three times daily for postoperative analgesia. Additionally, as is routinely done for postoperative pain management in our hospital's orthopedic department, 1 mg/kg tramadol will be administered intravenously as rescue analgesia if the patient's Numerical Rating Scale (NRS) score is 4 or higher (Rescue analgesia is an additional analgesic procedure performed when pain persists despite routine analgesic treatment). Tramadol dosing intervals will be planned to be no less than 6 hours, and the maximum daily tramadol dose will not exceed 400 mg. The total number of analgesic medications (NSAIDs or opioids) used in addition to the nerve block administered for pain control within 24 hours postoperatively will be recorded. For postoperative patient monitoring, patients will be evaluated by a physician who is unaware of the type of block administered.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Grup P-Pericapsular Nerve Block
Among the patients taken to the preoperative preparation room in the operating room, those who received routine ultrasound-guided pericapsular nerve block (PENG) following routine preoperative monitoring will be added to Group P. Pain measurement will be evaluated according to the NRS scale.
No interventions assigned to this group
Grup Q-Anterior Quadratus Lumborum Block
Among the patients taken to the preoperative preparation room in the operating room, those who underwent routine ultrasound-guided anterior quadratus lumborum (QLB-3) following routine preoperative monitoring will be added to Group Q. Pain measurement will be evaluated according to the NRS scale.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with ASA I, II, or III risk scores
* Patients aged 30-85
Exclusion Criteria
* Patients undergoing emergency surgery
* Patients who refuse to participate in the study or wish to withdraw afterward
* Patients with cognitive dysfunction such as Alzheimer's, dementia, or delirium
* Patients with a history of local anesthetic drug toxicity
* Patients with an infection in the area where the block will be performed
* Patients with bleeding diatheses
* Patients undergoing additional surgery or additional anesthetic procedures (general anesthesia)
* Patients with a history of chronic opioid use and those receiving neuropathic pain treatment
30 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erzincan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DİDEM ONK
Professor Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erzincan Üniversitesi, Erzincan, Merkez 24100
Erzincan, Merkez, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ErzincanU-ANESTEZİ-DO-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.